JBS N.V. Gains Losses On Fair Value Adjustment Biological Assets
JBS N.V. (JBS) reported Gains Losses On Fair Value Adjustment Biological Assets of $19.15 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Income Statement › Other Income
ifrs-full:GainsLossesOnFairValueAdjustmentBiologicalAssets · last filed 2026-03-25
- JBS N.V. gains losses on fair value adjustment biological assets for the quarter ending 2025-12-31 was -$47.91M, a 146.68% decline year-over-year.
- JBS N.V. gains losses on fair value adjustment biological assets for the quarter ending 2024-12-31 was $102.63M.
| Period end | Gains Losses On Fair Value Adjustment Biological Assets 3 month | Gains Losses On Fair Value Adjustment Biological Assets 9 month | Gains Losses On Fair Value Adjustment Biological Assets 12 month |
|---|---|---|---|
| 2025-12-31 | -$47.91M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $19.15M 20-F · filed 2026-03-25 | |
| 2025-09-30 | $67.06M 6-K · filed 2025-11-13 | ||
| 2024-12-31 | $102.63M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-25 | $158.60M 20-F · filed 2026-03-25 | |
| 2024-09-30 | $55.97M 6-K · filed 2025-11-13 | ||
| 2023-12-31 | -$85.02M 20-F · filed 2026-03-25 |